-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Invivo Therapeutics Holdings Corp. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2010 to Q3 2023.
- Invivo Therapeutics Holdings Corp. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2023 was 3.11M shares, a 123% increase year-over-year.
- Invivo Therapeutics Holdings Corp. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 1.54M shares, a 16.1% increase from 2021.
- Invivo Therapeutics Holdings Corp. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 1.32M shares, a 80.8% decline from 2020.
- Invivo Therapeutics Holdings Corp. annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 6.9M shares.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)